Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS

NCT ID: NCT06407609 Phase: NA Status: COMPLETED Enrollment: 64 Completion: 2023-03-03

Conditions

Boswellia Serrata, Irritable Bowel Syndrome

Interventions

Curcuma and boswellia extracts plus low fodmap diet, Low Foodmap diet

Summary

Small bowel dysbiosis (SBD), is a frequent finding in subjects with irritable bowel syndrome (IBS). The formula-tion in sunflower lecithin (Phytosome) of Curcuma longa and Boswellia serrata demonstrated beneficial effects on intestinal microbiota. The aim of this study was to evaluate the effect of a lecithin-based delivery formulation of Curcuma longa and of Boswellia serrata extracts (CUBO), on SBD in IBS subjects.

Primary Outcome

Evaluate the effect of Lecithin formulation on small bowel dysbiosis

Source

ClinicalTrials.gov